“Reduction of cardiovascular risk in patients with metabolic syndrome in a community health center after a pharmaceutical care program of pharmacotherapy follow-up”, Braz. J. Pharm. Sci., vol. 48, nº 3, p. 435–446, set. 2012, doi: 10.1590/S1984-82502012000300010.